LINC00908 Inactivates Wnt/β‐Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2
Cancer Medicine · 2025
DOI: 10.1002/cam4.70887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Han Guan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplastic Stem Cells, Glycogen Synthase Kinase 3 beta, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changzhou Health Commission Project, "512 Talent Cultivation Program" of Bengbu Medical College, First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars.
Abstract (Originalsprache)
Background
Chemotherapy and androgen‐deprivation treatment are the curative approaches utilized to suppress prostate cancer (PCa) progression. However, drug resistance and metastasis are extensive and hard to overcome even though remarkable progress has been made in recent decades. The cancer stem cell‐related theoretical model explains the distinct molecular characteristics of cancer, its relapse, metastasis, and drug resistance. Meanwhile, noncoding RNA functions in the formation of drug resistance and metastasis in most cancers. The long intergenic nonprotein coding RNA 908 (LINC00908) has been reported to restrain cell proliferation, migration, and invasion of some cancers like triple‐negative breast cancer, diffuse large B‐cell lymphoma, PCa, and so on. However, its role in stemness for PCa remains unclear.
Methods
We delved into the impact of LINC00908 in PCa cell stemness and the principal molecular mechanism. Then, the impact of LINC00908 on PCa cell stemness and its corresponding mechanism was explored by using functional assays and bioinformatics evaluation.
Results
We found that LINC00908 was low‐expressed in PCa cells, and it exerted suppressive functions in PCa cell stemness and tumor growth. Additionally, we revealed that LINC00908 down‐regulation was mediated by the HDAC2‐p300‐YY1 transcription complex. Moreover, LINC00908 up‐regulated glycogen synthase kinase 3 beta (GSK3B) via sponging miR‐3179. Meanwhile, LINC00908 deployed DEAD‐box helicase 3 X‐linked (DDX3X) to facilitate the stabilization of F‐box and WD repeat domain containing 2 (FBXW2) mRNA. Importantly, LINC00908 enhanced GSK3B and FBXW2 expression to induce the ubiquitination of β‐catenin protein, leading to Wnt pathway inactivation.
Conclusion
These results reveal that LINC00908 inhibits PCa cell stemness via inactivating the GSK3B/FBXW2‐regulated Wnt pathway, which might enrich people's knowledge of PCa stemness and provide some new potential biomarkers for PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
- Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.
- Department of Urology, Changzhou JinTan First People's Hospital, Changzhou, China.
- Department of Urology, Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi, China.
- Department of Laboratory, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.
- Institute of Medical Phenomics Research, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.
ORCID-Profile: Han Guan, Lilin Wan, Ninghan Feng, Zonghao You
Förderung
- Changzhou Health Commission Project
- "512 Talent Cultivation Program" of Bengbu Medical College
- First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars
- The General Project of Medical Research of Jiangsu Health and Wellness Committee
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Doctor of Entrepreneurship and Innovation in Jiangsu Province
- 2020 Provincial Natural Youth Project
Zitieren
APA
Guan, H., Hu, Q., Wan, L., Wang, C., Xue, Y., Feng, N., Zhao, C., Chen, M., & You, Z. (2025). LINC00908 Inactivates Wnt/β‐Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2. Cancer Medicine. https://doi.org/10.1002/cam4.70887
Vancouver
Guan H, Hu Q, Wan L, Wang C, Xue Y, Feng N, et al. LINC00908 Inactivates Wnt/β‐Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2. Cancer Medicine. 2025. doi:10.1002/cam4.70887
BibTeX
@article{Guan2025,
author = {Guan, Han and Hu, Qiang and Wan, Lilin and Wang, Can and Xue, Yifeng and Feng, Ninghan and Zhao, Chenggui and Chen, Ming and You, Zonghao},
title = {LINC00908 Inactivates Wnt/β‐Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70887}
}
EUVIMED